Sermorelin
(GHRH Analog – Growth Hormone Releasing Hormone 1-29)
Sermorelin is a synthetic peptide analog of the first 29 amino acids of growth hormone-releasing hormone (GHRH), the portion responsible for stimulating endogenous growth hormone (GH) release. It is widely studied for its applications in age-related GH decline, recovery, and metabolic support. Current areas of research include:
-
Endogenous GH Support
Sermorelin is being investigated for its ability to stimulate the natural release of growth hormone from the anterior pituitary. -
Tissue Repair and Recovery
Researchers are exploring its role in supporting soft tissue regeneration, lean mass preservation, and post-stress recovery. -
Age-Related Hormonal Decline
It is also being studied as a model for restoring youthful growth hormone pulsatility and downstream anabolic effects.
How It Works
Sermorelin mimics endogenous GHRH by binding to GHRH receptors on the anterior pituitary, promoting the release of growth hormone in a pulsatile, physiologically appropriate manner. Unlike direct GH administration, Sermorelin stimulates the body’s own feedback-regulated secretion, helping maintain balance across the growth hormone–IGF-1 axis. This makes it a preferred tool in research examining natural GH optimization, recovery, and age-associated endocrine function.
⚠️ Important Notice:
This product is sold strictly for laboratory research purposes only. It is not for human or animal use, and not for therapeutic or diagnostic applications.
By purchasing, you confirm that you are a qualified individual using this product in accordance with all applicable laws and research regulations.
